Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades
Open Access
- 26 February 2022
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (3) , 1-21
Abstract
Olfactomedin-4 (OLFM4) is an olfactomedin-domain-containing glycoprotein, which regulates cell adhesion, proliferation, gastrointestinal inflammation, innate immunity and cancer metastasis. In the present study we investigated its role in skin regeneration. We found that OLFM4 expression is transiently upregulated in the proliferative phase of cutaneous wound healing in humans as well as in mice. Moreover, a significant increase in OLFM4 expression was detected in the skin of lesional psoriasis, a chronic inflammatory disease characterized by keratinocyte hyperproliferation. In vitro experiments demonstrated that OLFM4 selectively stimulated keratinocyte proliferation and increased both keratinocyte and fibroblast migration. Using proteotranscriptomic pathway analysis we revealed that transcription factors POU5F1/OCT4 and ESR1 acted as hubs for OLFM4-induced signalling in keratinocytes. In vivo experiments utilizing mouse splinted full-thickness cutaneous wound healing model showed that application of recombinant OLFM4 protein can significantly improve wound healing efficacy. Taken together, our results suggest that OLFM4 acts as a transiently upregulated inflammatory signal that promotes wound healing by regulating both dermal and epidermal cell compartments of the skin.Keywords
Funding Information
- Eesti Teadusagentuur (PRG057, PSG737)
This publication has 49 references indexed in Scilit:
- Olfactomedin-4 Regulation by Estrogen in the Human Endometrium Requires Epidermal Growth Factor SignalingThe American Journal of Pathology, 2010
- Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infectionProceedings of the National Academy of Sciences, 2010
- Olfactomedin 4 (GW112, hGC-1) is an independent prognostic marker for survival in patients with colorectal cancerExperimental and Therapeutic Medicine, 2010
- Serum olfactomedin 4 (GW112, hGC‐1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patientsInternational Journal of Cancer, 2009
- Wound repair at a glanceJournal of Cell Science, 2009
- The genetic polymorphisms of POU5F1 gene are associated with psoriasis vulgaris in ChineseJournal of Dermatological Science, 2007
- Olfactomedin 4 promotes S‐phase transition in proliferation of pancreatic cancer cellsCancer Science, 2007
- Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2Blood, 2006
- The glycoprotein hGC-1 binds to cadherin and lectinsExperimental Cell Research, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003